Signature Estate & Investment Advisors LLC Sells 500 Shares of Aflac Incorporated (NYSE:AFL)

Signature Estate & Investment Advisors LLC reduced its position in Aflac Incorporated (NYSE:AFL) by 2.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,659 shares of the financial services provider’s stock after selling 500 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in Aflac were worth $1,827,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Nwam LLC bought a new stake in shares of Aflac during the third quarter worth about $221,000. Great Valley Advisor Group Inc. increased its holdings in Aflac by 5.9% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 3,762 shares of the financial services provider’s stock worth $421,000 after purchasing an additional 209 shares in the last quarter. Kingsview Wealth Management LLC raised its stake in shares of Aflac by 5.7% in the third quarter. Kingsview Wealth Management LLC now owns 13,410 shares of the financial services provider’s stock worth $1,499,000 after purchasing an additional 718 shares during the last quarter. Daiwa Securities Group Inc. lifted its holdings in shares of Aflac by 10.0% in the third quarter. Daiwa Securities Group Inc. now owns 64,290 shares of the financial services provider’s stock valued at $7,188,000 after purchasing an additional 5,858 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Aflac during the third quarter valued at approximately $730,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Activity at Aflac

In related news, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 55,546 shares of company stock worth $5,863,616. 0.90% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on AFL shares. BMO Capital Markets began coverage on Aflac in a research note on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective on the stock. Morgan Stanley raised their price target on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. Barclays reduced their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research report on Friday, February 7th. Keefe, Bruyette & Woods dropped their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research report on Wednesday, February 12th. Finally, JPMorgan Chase & Co. upped their target price on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $103.36.

Aflac Stock Down 0.1 %

Shares of NYSE AFL opened at $109.56 on Wednesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The stock has a market capitalization of $59.88 billion, a PE ratio of 11.41, a P/E/G ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50. The business’s fifty day moving average price is $106.21 and its 200-day moving average price is $107.62.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, equities research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.